Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Bacterial and viral antigens and toxins represent a broad class of pathogen-derived molecules that are central to the pathogenesis of infectious diseases and serve as the primary targets for vaccines and immunotherapies. Antigens are typically proteins, polysaccharides, or lipids that are recognized by the host's immune system, such as the spike protein of viruses or the cell wall components of bacteria (National Institute of Allergy and Infectious Diseases, 2023). Toxins are specialized proteins or lipopolysaccharides (e.g., exotoxins and endotoxins) secreted or released by bacteria to damage host cells or suppress the immune response (StatPearls, 2023). These molecules facilitate host cell attachment, entry, and the subversion of cellular processes to favor pathogen replication. Therapeutic strategies targeting these molecules include vaccines that induce long-term memory, monoclonal antibodies that neutralize viral entry or toxin activity, and antitoxins for immediate treatment of toxemia (CDC, 2022). Because this group includes thousands of distinct molecular entities, drug development is highly specific to the individual pathogen and its unique virulence factors. Understanding the structural biology of these antigens and toxins is essential for designing effective countermeasures against infectious diseases (Nature Reviews Microbiology, 2021).
Neutralization of viral entry, neutralization of bacterial exotoxins, opsonization for phagocytosis, complement activation, and induction of active immunity via vaccination.
9 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bacterial and viral antigens and toxins.